Comparison of 6-week PMTCT outcomes for HIV-exposed and HIV-unexposed infants in the era of lifelong ART: Results from an observational prospective cohort study.
Appolinaire TiamSeble G KassayeRhoderick MachekanoVincent TukeiMichelle M GillMajoalane MokoneMosilinyane LetsieMots'oane TsietsoIrene SeipatiJanety BarasaAnthony IsavwaThorkild TylleskärLaura GuayPublished in: PloS one (2019)
Implementation of universal maternal ART lowers MTCT at 6 weeks of age with no differences in congenital anomalies or early mortality between HIV exposed Infants and HIV unexposed infants. However, HIV exposed infants continue to have high rates of prematurity despite improved maternal health on ART.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv testing
- hiv aids
- hepatitis c virus
- men who have sex with men
- healthcare
- primary care
- public health
- south africa
- birth weight
- metabolic syndrome
- adipose tissue
- clinical trial
- pregnant women
- cardiovascular events
- risk assessment
- gestational age
- body mass index
- cross sectional